Anesthesia & Analgesia · 2010 · 14 citations · 10 references
MedicineAnesthesiologySurgeryAnesthesiaPain ManagementPain MedicineAnalgesiaAnesthetic PharmacologyBreast SurgeryOpioid-sparing Pain ManagementPain OutcomesPostoperative PainDonor Site CareDonor Site Pain ManagementPain Management After SurgeryPerioperative Pain PharmacotherapyPostoperative Analgesia After Abdominal SurgeryPostoperative Opioid AnalgesiaRescue Medication AdministrationRescue Medication Use
BACKGROUND: Deep inferior epigastric perforator flap surgery usually results in postoperative pain from the donor site requiring opioids. METHOD: We examined the effect of bupivacaine 2.5 mg/mL, 20 mL given every third hour for 72 hours postoperatively through 2 thin catheters placed on the donor site in a double-blind placebo-controlled study consisting of 2 x 20 patients. RESULTS: The bupivacaine group had significantly reduced pain at rest and during coughing. The placebo group needed 2 to 3 times more opioids in the 72-hour observation period. No difference was seen in the frequency of nausea or the consumption of antiemetic drugs. CONCLUSION: We conclude that intermittent delivery of bupivacaine at the abdominal donor site significantly reduces the postoperative pain and need for narcotic rescue medication.
10
The Analgesic Efficacy of Patient-Controlled Ropivacaine Instillation After Cesarean Delivery
Brian Fredman, Arie Shapiro, Edna Zohar et al. · Anesthesia & Analgesia · 2000 · 176 citations
Medicine, Anesthesiology, Surgery +17
Postoperative Morphine Requirements of Free TRAM and DIEP Flaps
Stephen S. Kroll, Cindy A. Koutz, Howard N. Langstein et al. · Plastic & Reconstructive Surgery · 2001 · 168 citations
Medicine, Plastic Surgery, Surgery +17